InnoCan Pharma Corporation INNPF
1.29 USD 0.00 (+0.00%)
At close·Nov 3, 2026, 4:00 PM EST
- YTD
- -82.16%
- 1 year
- -89.80%
Altman Z-Score
-1.02 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
P/E -28.9×
P/S 1.2×
P/B 5.8×
P/FCF 67.6×
EV/EBITDA 205×
EV/Sales 1.0×
FCF Yield 1.5%
Gross Margin 89.9%
Operating Margin -4.7%
Net Margin -4.2%
ROE -20.1%
ROIC 54.9%
ROA -10.7%
Revenue -9.6%
Operating Income -0.6%
EPS (diluted) 40.5%
Free Cash Flow 130.1%
Current Ratio 7.7×
Quick Ratio 6.1×
Debt / Equity 0.2×
Net Debt / EBITDA -44.3×
Interest Coverage -418×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31